The Market for Bioelectronic Medicine: 2019-2023

250 pages

Publication Date: April 2019

This newly published market research report is the most authoritative and comprehensive publication available covering the emerging bioelectronic medicine industry. The report takes an in-depth look at the technology, markets, competitors, research, and growth rates in all key applications areas in the years 2019 through 2023. It forecasts U.S. and worldwide revenue, compound annual growth rates, and competitor market shares for bioelectronic medicine devices in several key indications, including hypertension, gastrintestinal disorders, bowel and bladders disorders, cardiac disorders, metabolic disorders, and ENT disorders. The report also includes coverage of and places in context more traditional neuromodulation therapies for treating pain, epilepsy, movement disorders, psychiatric disorders, and sensory disorders.

The Market for Bioelectronic Medicine: 2019-2023 covers in detail all the key public companies and the most significant emerging and more established non-public firms in the industry. The report also features in-depth profiles of major research institutions in the U.S. and abroad involved with bioelectronic medicine developments, and traces the commercial activity that is emerging from each.

The report not only looks at future financial projections, it covers likely technology trends and product developments that will impact the industry in the years ahead, such as:

  • The role of noninvasive and wearable systems as an alternative to implanted devices.
  • Closed-loop therapies that modify stimulation parameters based on relevant biomarkers.
  • Pay-per-dose economic models that conform to pharmaceutical distribution strategies.

The Market for Bioelectronic Medicine: 2019-2023 examines the key role that government funding agencies such as the NIH and DARPA are playing in the development of the industry. It also profiles private and non-government funding sources such as venture capital firms as well as investment from key strategic players..

Contents

  1. Introduction and Background
  2. Principles of Bioelectronic Medicine
  3. Diseases, Disorders and Conditions
  4. Market Size and Growth
  5. Competitors
  6. Research Institutions
  7. Company Profiles
  8. Research Institution Profiles
  9. Funding Organizations
  10. Future Directions
  11. Company Listings

Tables and Figures

  • U.S. and Worldwide Market for Bioelectronic Medicine
  • U.S. and Worldwide Market for Infalammatory Disorders
  • U.S. and Worldwide Market for Cardiac
  • U.S. and Worldwide Market for Gastrointestinal Disorders
  • U.S. and Worldwide Market for Metabolic Disorders
  • U.S. and Worldwide Market for Hypertension
  • U.S. and Worldwide Market for Bowel and Bladder Disorders
  • Market Share, SNS and Tibial Nerve Stimulation Systems
  • Market Share, Bioelectronic Hypertension Therapies
  • Several Others

Companies Profiled

  • Medtronic
  • Abbott
  • Axonics Modulation
  • CVRx
  • SetPoint Medical
  • electroCore Medical
  • LivaNova
  • Galvani Bioelectronics
  • Endostim
  • Neuspera
  • Inspire Medical
  • Dozens More

Special Prepublication Offer!

Order The Market for Bioelectronic Medicine: 2019-2023 before it is released and you will receive a copy of our sister publication, The Market for Neurotechnology: 2018-2022 now, at no extra charge. You will receive The Market for Bioelectronic Medicine: 2019-2023 when it is published in April 2019.

Order Report


      

©2019 Neurotech Reports. All rights reserved.